Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Emicizumab, the bispecific antibody to factors IX/IXa and X/Xa, potentiates coagulation function in factor XI-deficient plasma in vitro.
Journal of thrombosis and haemostasis : JTH·2018
Common themes and challenges in hemophilia care: a multinational perspective.
Hematology (Amsterdam, Netherlands)·2018
The Japanese Immune Tolerance Induction (J-ITI) study in haemophilia patients with inhibitor: Outcomes and successful predictors of ITI treatment.
Haemophilia : the official journal of the World Federation of Hemophilia·2018
Routine measurements of factor VIII activity and inhibitor titer in the presence of emicizumab utilizing anti-idiotype monoclonal antibodies.
Journal of thrombosis and haemostasis : JTH·2018
Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti-factor IXa/factor X bispecific antibody emicizumab.
Journal of thrombosis and haemostasis : JTH·2018
Clot waveform analysis using CS-2000i™ distinguishes between very low and absent levels of factor VIII activity in patients with severe haemophilia A.
Haemophilia : the official journal of the World Federation of Hemophilia·2017
Harnessing Cloud-Based Technology to Train School Nurses: A Type 1 Diabetes Exemplar.
NASN school nurse (Print)·2026
From Mandate to Maintenance: Quantifying the association between menstrual product availability and school attendance.
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC·2026